News for Healthier Living

Research Identifies New Ways To Supercharge Cancer Immunotherapy

* A protein called STUB1 weakens the cancer-killing power of immune T cells by blocking key signals they need to attack tumors. * Disabling STUB1 in lab experiments strengthened T cells' response to the immune-boosting molecule IL-27, slowing tumor growth and prolonging mouse survival. * The findings open the door to new approaches that could make cancer immunotherapy work for more patients.

August 12, 2025


August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025

August 6 2025

August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025